{"id":"https://openalex.org/W2886830404","doi":"https://doi.org/10.1007/s11096-018-0711-z","title":"Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology","display_name":"Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology","alternate_titles":[],"publication_year":2018,"publication_date":"2018-08-01","ids":{"openalex":"https://openalex.org/W2886830404","doi":"https://doi.org/10.1007/s11096-018-0711-z","mag":"2886830404","pmid":"https://pubmed.ncbi.nlm.nih.gov/30094557","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6132975"},"language":"en","primary_location":{"id":"doi:10.1007/s11096-018-0711-z","doi":"https://doi.org/10.1007/s11096-018-0711-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11096-018-0711-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11096-018-0711-z.pdf","source":{"id":"https://openalex.org/S2498751418","display_name":"International Journal of Clinical Pharmacy","issn_l":"2210-7703","issn":["2210-7703","2210-7711"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Pharmacy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2886830404"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11096-018-0711-z.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017777829","display_name":"Paolo Baldo","orcid":"https://orcid.org/0000-0002-5106-7120","observed_orcids":["https://orcid.org/0000-0002-5106-7120"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Paolo Baldo","raw_affiliation_strings":["Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy. pbaldo@cro.it","Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy"],"raw_orcid":"https://orcid.org/0000-0002-5106-7120","affiliations":[{"raw_affiliation_string":"Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy. pbaldo@cro.it","institution_ids":["https://openalex.org/I4210128630"]},{"raw_affiliation_string":"Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037266730","display_name":"Sara Francescon","orcid":"https://orcid.org/0000-0001-8042-7773","observed_orcids":["https://orcid.org/0000-0001-8042-7773"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Francescon","raw_affiliation_strings":["Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036756459","display_name":"Giulia Fornasier","orcid":"https://orcid.org/0000-0003-3055-7080","observed_orcids":["https://orcid.org/0000-0003-3055-7080"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Fornasier","raw_affiliation_strings":["Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Unit, CRO Aviano IRCCS, National Cancer Institute, Aviano, Italy","institution_ids":["https://openalex.org/I4210128630"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017777829"],"corresponding_institution_ids":["https://openalex.org/I4210128630"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":1.2992,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.7479302,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"40","issue":"4","first_page":"748","last_page":"753"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8790000081062317},{"id":"https://openalex.org/keywords/terminology","display_name":"terminology","score":0.6899999976158142},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9909999966621399},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.9739999771118164},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.8820000290870667}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.9738990068435669},{"id":"https://openalex.org/C547195049","wikidata":"https://www.wikidata.org/wiki/Q1725664","display_name":"Terminology","level":2,"score":0.7026288509368896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6684771180152893},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.6263514161109924},{"id":"https://openalex.org/C2781140086","wikidata":"https://www.wikidata.org/wiki/Q557945","display_name":"Confusion","level":2,"score":0.5410735607147217},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.49837803840637207},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.4473860263824463},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.4331362247467041},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3039121627807617},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29013243317604065},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2307870090007782},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.14752435684204102},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.11967629194259644},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.08744382858276367},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.07593527436256409},{"id":"https://openalex.org/C11171543","wikidata":"https://www.wikidata.org/wiki/Q41630","display_name":"Psychoanalysis","level":1,"score":0.0},{"id":"https://openalex.org/C105639569","wikidata":"https://www.wikidata.org/wiki/Q582577","display_name":"Economic policy","level":1,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009626","descriptor_name":"Terminology as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057188","descriptor_name":"Workflow","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061214","descriptor_name":"Patient Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s11096-018-0711-z","doi":"https://doi.org/10.1007/s11096-018-0711-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11096-018-0711-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11096-018-0711-z.pdf","source":{"id":"https://openalex.org/S2498751418","display_name":"International Journal of Clinical Pharmacy","issn_l":"2210-7703","issn":["2210-7703","2210-7711"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Pharmacy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5090693","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6132975","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30094557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30094557","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6132975","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6132975/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Clin Pharm","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s11096-018-0711-z","doi":"https://doi.org/10.1007/s11096-018-0711-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11096-018-0711-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11096-018-0711-z.pdf","source":{"id":"https://openalex.org/S2498751418","display_name":"International Journal of Clinical Pharmacy","issn_l":"2210-7703","issn":["2210-7703","2210-7711"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2886830404.pdf","grobid_xml":"https://content.openalex.org/works/W2886830404.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W1921849213","https://openalex.org/W1989928752","https://openalex.org/W1995201595","https://openalex.org/W2119805714","https://openalex.org/W2150425860","https://openalex.org/W2153972688","https://openalex.org/W4249078372"],"related_works":["https://openalex.org/W1971020009","https://openalex.org/W2603490118","https://openalex.org/W604392835","https://openalex.org/W2090045359","https://openalex.org/W3186054035","https://openalex.org/W2938487258","https://openalex.org/W4241361509","https://openalex.org/W4416741683","https://openalex.org/W1523596586","https://openalex.org/W2395058629"],"abstract_inverted_index":{"The":[0],"terminology":[1,29],"used":[2,54],"in":[3,55,65,73],"pharmacovigilance":[4,62,80],"can":[5,30],"cause":[6],"confusion,":[7],"because":[8],"there":[9],"are":[10],"similar":[11],"terms":[12,53],"that":[13],"describe":[14],"different":[15],"phenomena":[16],"(e.g.":[17],"adverse":[18,20,38],"reactions,":[19,22],"drug":[21,39],"and":[23,41],"side":[24],"effects).":[25],"Incorrect":[26],"use":[27],"of":[28,37,45],"have":[31],"negative":[32],"effects":[33],"on":[34,42],"the":[35,43,50,61,66,76],"reporting":[36],"reactions":[40],"interpretation":[44],"these":[46],"reports.":[47],"To":[48],"explain":[49],"most":[51],"common":[52,79],"pharmacovigilance,":[56],"this":[57],"article":[58,77],"first":[59],"describes":[60],"workflow":[63],"process":[64],"European":[67],"Union":[68],"and,":[69],"as":[70],"an":[71],"example,":[72],"Italy.":[74],"Then,":[75],"reviews":[78],"terms.":[81]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2886830404","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-08-22T00:00:00"}
